life science investing Resverlogix Announces New Research Highlighting Apabetalone's Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19
Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International Conference on Alzheimer’s & Parkinson’s Diseases
Equity Metals Reports First Assays from No. 3 North 2025 Expansion Drilling, Including 540 g/t AgEq over 3.5m, Silver Queen Property, BC
